Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group | Blood Cancer Journal
Fehérjebiotechnológia
NYXTHRACIS, INN-obiltoxaximab
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when | Haematologica
Fehérjebiotechnológia
Doktori (PhD) értekezés
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma | Nature Communications
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT | Blood Cancer Journal
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma | Nature Communications
Fehérjebiotechnológia
Prognostic Stratification of Multiple Myeloma Using Clinicog... : HemaSphere
Doktori (PhD) értekezés
Doktori (PhD) értekezés
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group | Blood Cancer Journal
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when | Haematologica
Display of a 47-year-old male (patient #10) with multiple myeloma R-ISS... | Download Scientific Diagram
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma | Nature Communications
Prognostic Stratification of Multiple Myeloma Using Clinicog... : HemaSphere
Fehérjebiotechnológia
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when | Haematologica
BIOTERMÉK TECHNOLÓGIA
Display of a 47-year-old male (patient #10) with multiple myeloma R-ISS... | Download Scientific Diagram
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT | Blood Cancer Journal
